Antengene Research & Development Day

When:

Time:

8:30 am - 11:30 am EST

Event Description

Dear Investors and Analysts, Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that it will host its first R&D Day for the investment community to review Antengene’s R&D pipeline and important updates.
Antengene’s R&D Day will include presentations from:
  • Dr. Jay Mei Founder, Chairman and CEO
  • Dr. Kevin Lynch Chief Medical Officer
  • Dr. Bo Shan Chief Scientific Officer
  • Mr. John Chin Chief Business Officer
  • Mr. Thomas Karalis VP, Head of Asia Pacific Region
  • Dr. Bing Hou Executive Director, Drug Discovery
  • Dr. Aihua Wang Executive Director, Clinical Development
  • Dr. Guo Zhi Executive Medical Director
The meetings will be held virtually in English on November 16, 2021, and on-site in Mandarin on November 18, 2021. A live webcast will be available on the Antengene website under “Investor Relations”, on the Event Calendar page.

The post Antengene Research & Development Day appeared first on LifeSci Advisors.

Ready to realize your future?